🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery

Sosei Group Corporation (Sosei Heptares) in Japan and PharmEnable, a UK drug discovery company, have announced...

January 12, 2021 | Tuesday | News
Fujifilm injects $2B into large-scale cell culture manufacturing site in US

FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...

January 8, 2021 | Friday | News
Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China

The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...

January 6, 2021 | Wednesday | News
Singapore launches spin-off to develop treatment for intractable diseases

The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...

December 24, 2020 | Thursday | News
Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...

December 4, 2020 | Friday | News
Eisai and Wren Therapeutics collaborate for potential treatment of synucleinopathies

Japanese firm Eisai Co., Ltd. and US based Wren Therapeutics Ltd. have announced that the companies have entered into an...

December 1, 2020 | Tuesday | News
Korea's OliPass advisory board to evaluate osteoarthritis pain killer drug development

OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...

November 25, 2020 | Wednesday | News
Koru Lifescience identifies drug compounds beneficial for COVID-19 trials

New Zealand's Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, has ident...

November 24, 2020 | Tuesday | News
Insilico announces AI-powered drug discovery collaboration with Janssen

Hong Kong-based Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecu...

November 11, 2020 | Wednesday | News
Australia evaluates hyperimmune immunoglobulin treatment for COVID-19

Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...

November 9, 2020 | Monday | News
Cerecin's Tricaprilin receives ODD in the Treatment of infantile spasms

Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the ...

October 30, 2020 | Friday | News
CStone inks deal worth $353.5M for new antibody drug conjugate

CStone Pharmaceuticals has announced a licensing agreement with LegoChem Biosciences, Inc., (LCB) for the development an...

October 29, 2020 | Thursday | News
ASLAN to develop next-gen DHODH inhibitor in autoimmune conditions

ASLAN Pharmaceuticals, clinical-stage immunology focused biopharmaceutical company developing innovative treatments to t...

October 16, 2020 | Friday | News
Prestige Biopharma receives ODD to its Pancreatic Cancer drug

Prestige BioPharma Ltd. on 13 Oct 2020 announced that the European Medicines Agency (EMA) Orphan Drug Commission (C...

October 14, 2020 | Wednesday | News
Antengene partners with WuXi Biologics for innovative oncology medicines

Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...

October 14, 2020 | Wednesday | News
Eisai collaborates with University of Tokyo for protein degradation drug discovery

The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...

October 13, 2020 | Tuesday | News
Antengene establishes new drug discovery centre in Shanghai

Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...

October 13, 2020 | Tuesday | News
Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis

Marinomed Biotech AG, a Vienna-based biopharmaceutical company, develops groundbreaking treatment for autoimmune gastrit...

October 9, 2020 | Friday | News